HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 3.920
-0.110 (-2.73%)
Aug 10, 2026, 4:00 PM EST
HLS Therapeutics Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 123 | 151 | 125 | 126 | 318 | 487 | |
Market Cap Growth | -22.36% | 20.64% | -0.99% | -60.33% | -34.66% | -15.02% |
Enterprise Value | 166.71 | 205.33 | 196.42 | 217.82 | 425.72 | 586.83 |
Last Close Price | 3.92 | 4.82 | 3.93 | 3.95 | 9.83 | 15.00 |
Forward PE | - | 50.92 | 50.92 | 50.92 | 50.92 | 185.98 |
PS Ratio | 1.58 | 1.98 | 1.54 | 1.51 | 3.81 | 6.42 |
PB Ratio | 1.50 | 1.78 | 1.22 | 0.97 | 1.87 | 2.40 |
P/FCF Ratio | 4.44 | 6.49 | 10.90 | 6.05 | 13.87 | 23.51 |
P/OCF Ratio | 4.40 | 6.41 | 10.88 | 6.03 | 13.84 | 23.44 |
EV/Sales Ratio | 2.14 | 2.70 | 2.42 | 2.61 | 5.10 | 7.74 |
EV/EBITDA Ratio | 7.17 | 9.16 | 7.85 | 10.69 | 19.96 | 19.50 |
EV/FCF Ratio | 6.04 | 8.84 | 17.13 | 10.44 | 18.57 | 28.34 |
Debt / Equity Ratio | 0.78 | 0.84 | 0.94 | 0.93 | 0.80 | 0.62 |
Debt / EBITDA Ratio | 2.73 | 3.15 | 3.86 | 5.93 | 6.36 | 4.21 |
Debt / FCF Ratio | 2.30 | 3.04 | 8.42 | 5.79 | 5.92 | 6.13 |
Net Debt / Equity Ratio | 0.57 | 0.65 | 0.70 | 0.71 | 0.63 | 0.49 |
Net Debt / EBITDA Ratio | 1.99 | 2.44 | 2.86 | 4.50 | 5.05 | 3.33 |
Net Debt / FCF Ratio | 1.68 | 2.35 | 6.24 | 4.39 | 4.70 | 4.83 |
Asset Turnover | 0.42 | 0.37 | 0.31 | 0.28 | 0.24 | 0.21 |
Inventory Turnover | 1.34 | 1.17 | 0.97 | 0.83 | 0.56 | 0.41 |
Quick Ratio | 0.71 | 0.75 | 1.10 | 1.22 | 1.02 | 1.18 |
Current Ratio | 1.00 | 1.11 | 1.57 | 1.65 | 1.42 | 1.58 |
Return on Equity (ROE) | -17.12% | -18.69% | -23.26% | -24.69% | -16.50% | -7.95% |
Return on Assets (ROA) | -3.79% | -3.56% | -3.62% | -7.28% | -7.18% | -2.47% |
Return on Invested Capital (ROIC) | -5.27% | -4.76% | -4.63% | -8.83% | -8.36% | -2.84% |
Return on Capital Employed (ROCE) | -4.96% | -4.41% | -3.31% | -8.43% | -8.15% | -2.50% |
FCF Yield | 22.51% | 15.41% | 9.17% | 16.54% | 7.21% | 4.25% |
Dividend Yield | - | 0.00% | 0.00% | 2.50% | 2.11% | 1.34% |
Payout Ratio | - | 0.00% | 0.00% | -8.71% | -21.03% | -39.05% |
Buyback Yield / Dilution | 1.28% | 0.98% | 1.31% | 0.52% | -0.77% | -1.48% |
Total Shareholder Return | 1.28% | 0.98% | 1.31% | 3.02% | 1.34% | -0.14% |